First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study

por da Silva, Michael Ruberson Ribeiro, dos Santos, Jéssica Barreto Ribeiro, Kakehasi, Adriana Maria, Almeida, Alessandra Maciel, Pimenta, Pedro Ricardo Kömel, Alvares-Teodoro, Juliana, Acurcio, Francisco de Assis
Publicado 2022